Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA5A | P35218 | 1/20 | 0.52 |
| ▸ | NT5E | P21589 | 1/20 | 0.43 |
| ▸ | FBP1 | P09467 | 3/20 | 0.42 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.42 |
| ▸ | TRPM2 | O94759 | 2/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.41 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.41 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.41 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.41 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.41 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenine SCHEMBL7996359 | 0.85 | TRPM2 (0.49) | CA5AFBP1HPRT1TRPM2TAS1R3 | |
| Adenine SCHEMBL11136514 | 0.85 | TRPM2 (0.49) | CA5AFBP1HPRT1TRPM2TAS1R3 | |
| Adenine SCHEMBL3921122 | 0.85 | TRPM2 (0.49) | CA5AFBP1HPRT1TRPM2TAS1R3 | |
| Ribose (Furanose) SCHEMBL4284369 | 0.84 | HIF1A (0.46) | NT5EADORA1SMN1; SMN2 | |
| SCHEMBL717431 | 0.83 | CA5A (0.39) | CA5AFBP1HPRT1TRPM2TAS1R3 | |
| Guanine SCHEMBL9861048 | 0.83 | PNP (0.52) | NT5EFBP1HPRT1UMPS | |
| SCHEMBL6305780 | 0.81 | CA5A (0.43) | CA5ANT5EFBP1HPRT1TAS1R3 | |
| Mercaptopurine Anhydrous SCHEMBL8627151 | 0.77 | FBP1 (0.44) | FBP1HPRT1TRPM2TAS1R3TAS1R1 | |
| SCHEMBL15167310 | 0.77 | TRPM2 (0.41) | TRPM2P2RY1P2RY11MACROD2SIRT6 | |
| SCHEMBL15166956 | 0.76 | TRPM2 (0.43) | TRPM2P2RY1P2RY11MACROD2SIRT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11364043-B2 | Methods and devices for endovascular therapy | CARDIOPROLIFIC INC. (US) | 2022-06-21 | — | — | US | disclosed |
| US-11116528-B2 | Methods and devices for endovascular therapy | CARDIOPROLIFIC, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| US-11039845-B2 | Methods and devices for endovascular therapy | CARDIOPROLIFIC INC. (US) | 2021-06-22 | — | — | US | disclosed |
| US-20170202949-A1 | DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE | PROVIDENCE HEALTH & SERVICES - OREGON (US) | 2017-07-20 | — | — | US | disclosed |
| US-20160367274-A1 | METHODS AND DEVICES FOR ENDOVASCULAR THERAPY | CARDIOPROLIFIC INC (US) | 2016-12-22 | — | — | US | disclosed |
| US-20160367275-A1 | METHODS AND DEVICES FOR ENDOVASCULAR THERAPY | CARDIOPROLIFIC INC (US) | 2016-12-22 | — | — | US | disclosed |
| US-20160270806-A1 | METHODS AND DEVICES FOR ENDOVASCULAR THERAPY | CARDIOPROLIFIC INC (US) | 2016-09-22 | — | — | US | disclosed |
| US-9375223-B2 | Methods and devices for endovascular therapy | CARDIOPROLIFIC INC. (US) | 2016-06-28 | — | — | US | disclosed |
| US-20140186292-A1 | DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE | PROVIDENCE HEALTH & SERVICES - OREGON (US) | 2014-07-03 | — | — | US | disclosed |
| US-20140142494-A1 | METHODS AND DEVICES FOR ENDOVASCULAR THERAPY | CARDIOPROLIFIC INC. | 2014-05-22 | — | — | US | disclosed |
| US-20130345617-A1 | METHODS AND DEVICES FOR REMOVAL OF TISSUE, BLOOD CLOTS AND LIQUIDS FROM THE PATIENT | CARDIOPROLIFIC INC. | 2013-12-26 | — | — | US | disclosed |
| EP-1912672-B1 | DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE | PROVIDENCE HEALTH SYSTEM (US) | 2013-09-04 | — | — | EP | disclosed |
| US-20130023897-A1 | Devices and Methods for Endovascular Therapies | CARDIOPROLIFIC INC. | 2013-01-24 | — | — | US | disclosed |
| US-20120215099-A1 | Methods and Apparatus for Endovascular Ultrasound Delivery | CARDIOPROLIFIC INC. | 2012-08-23 | — | — | US | disclosed |
| WO-2012026982-A1 | ULTRASOUND-ENHANCED STENOSIS THERAPY | WALLACE MICHAEL P (US) | 2012-03-01 | — | — | WO | disclosed |
| US-20090220530-A1 | DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE | PROVIDENCE HEALTH SYSTEM | 2009-09-03 | — | — | US | disclosed |
| EP-1912672-A2 | DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE | Providence Health System (US) | 2008-04-23 | — | — | EP | disclosed |
| WO-2007016340-A2 | DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE | PROVIDENCE HEALTH SYSTEM (US) | 2007-02-08 | — | — | WO | disclosed |
| US-20010039952-A1 | ULTRASOUND ENHANCED CHEMOTHERAPY | WALTER A. HACKER, PH. D | 2001-11-15 | — | — | US | disclosed |
| US-6308714-B1 | Ultrasound enhanced chemotherapy | CORAJE, INC. | 2001-10-30 | — | — | US | disclosed |